Consumer groups have demanded that dentists stop using a mercury-laden amalgam to fill tooth cavities. The FDA has promised to take the matter under consideration for further review. The FDA asked the panel to weigh in on whether the study — a review of 34 recent research studies — reflects current knowledge about the risks associated with the fillings. The FDA did not ask the panelists to discuss a ban.
Monthly Archives: September 2006
Boston Scientific Confirms Increased Risk Linked to its Stent
A leading stent manufacturer has admitted that there is an increased clot risk for those with Boston Scientific’s cardiac stent. It is the first acknowledgment by a stent maker of an increased risk of the dangerous side effect of stents, which are small wire-mesh tubes used to keep previously clogged arteries open. Drug-coated stents, which are coated with medicine to prevent the growth of tissue after implantation, have sales exceeding $5 billion a year in a market dominated by Boston Scientific and Johnson & Johnson.